Endo International Plc
(NASDAQ : ENDP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
3.44%16.5414.1%$318.35m
SHPGShire PLC Sponsored ADR
3.42%149.780.4%$211.23m
PRGOPerrigo Co. Plc
0.01%86.766.6%$134.94m
MNKMallinckrodt Plc
-0.09%21.3718.5%$118.92m
SAGESAGE Therapeutics, Inc.
6.12%95.4410.9%$106.75m
JAZZJazz Pharmaceuticals Plc
0.62%138.042.2%$77.00m
ENDPEndo International Plc
0.79%7.638.9%$67.47m
ICPTIntercept Pharmaceuticals, Inc.
0.71%62.2422.0%$50.61m
UTHRUnited Therapeutics Corporation
0.00%125.4114.5%$49.65m
PCRXPacira Pharmaceuticals, Inc.
4.34%44.5010.7%$49.15m
ADMSAdamas Pharmaceuticals, Inc.
8.36%33.5916.9%$42.85m
MDCOMedicines Company
0.71%31.4022.1%$39.84m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.91%126.387.6%$39.41m
ICLRICON Plc
0.77%118.354.1%$38.03m
PTLAPortola Pharmaceuticals, Inc.
0.93%51.277.8%$34.80m

Company Profile

Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The company operates through the following segments: U.S. Branded Pharmaceuticals, U.S. Generic pharmaceuticals and International Pharmaceuticals. The U.S. Branded Pharmaceuticals offers products that focus on the treatment and management of conditions in urology, urologic oncology, endocrinology, and orthopedics. The U.S. Generic pharmaceuticals segment consist of a differentiated product portfolio including high-barrier-to-entry products, first-to-file or first-to-market opportunities that are difficult to formulate, difficult to manufacture or face complex legal and regulatory challenges. The International Pharmaceuticals segment includes a variety of pharmaceutical products for the Canadian, Latin American, South African, and world markets. Endo International was founded on October 31, 2013 and is headquartered Dublin, Ireland.